TiNT: Trametinib in Neurofibromatosis type 1 associated tumours (ANZCTR) - Oct 2, 2026 - P2 | N=120 | Completed | Sponsor: Australian and New Zealand Children's Haematology/Oncology Group | Active, not recruiting ➔ Completed
Trial completion • Brain Cancer • Genetic Disorders • Glioma • Neurofibromatosis • Oncology • Pediatrics • Solid Tumor • NF1
|